StockData
Regencell Bioscience Holdings Ltd logo

Regencell Bioscience Holdings Ltd (RGC) stock

RGCNasdaqMedicinal Chemicals & Botanical Products
Financials through fiscal 2026, year ended Jun 30, 2026Last filing: 20-F on Oct 7, 2026Score 5/30
$4.69+0.14 (+3.08%)

Close on Nov 18, 2026Market cap $2.33BP/E –Yield –

Regencell Bioscience revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

No revenue figures for Regencell Bioscience

Regencell Bioscience has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Regencell Bioscience figures

See a number that looks wrong?